abrdn Healthcare Investors (NYSE:HQH) Stock Passes Below 50 Day Moving Average – Here’s Why

Shares of abrdn Healthcare Investors (NYSE:HQH) passed below its 50 day moving average during trading on Thursday . The stock has a 50 day moving average of $19.33 and traded as low as $18.96. abrdn Healthcare Investors shares last traded at $19.24, with a volume of 192,184 shares trading hands.

abrdn Healthcare Investors Stock Down 0.8%

The firm has a 50 day moving average price of $19.34 and a 200-day moving average price of $19.13.

abrdn Healthcare Investors Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Tuesday, June 30th. Investors of record on Thursday, May 21st will be paid a dividend of $0.61 per share. The ex-dividend date of this dividend is Thursday, May 21st. This represents a $2.44 dividend on an annualized basis and a dividend yield of 12.8%.

Institutional Inflows and Outflows

Several large investors have recently modified their holdings of the business. Bollard Group LLC purchased a new stake in shares of abrdn Healthcare Investors in the first quarter worth approximately $25,000. Geneos Wealth Management Inc. boosted its holdings in abrdn Healthcare Investors by 9,232.3% during the 2nd quarter. Geneos Wealth Management Inc. now owns 2,893 shares of the financial services provider’s stock valued at $45,000 after acquiring an additional 2,862 shares during the period. Flagship Harbor Advisors LLC purchased a new position in abrdn Healthcare Investors during the 4th quarter valued at $48,000. Advisory Services Network LLC bought a new position in abrdn Healthcare Investors in the 3rd quarter valued at $97,000. Finally, Global Retirement Partners LLC bought a new position in abrdn Healthcare Investors in the 4th quarter valued at $106,000. Hedge funds and other institutional investors own 32.60% of the company’s stock.

About abrdn Healthcare Investors

abrdn Healthcare Investors (NYSE:HQH) is a closed-end management investment company that seeks long-term capital appreciation and current income by investing primarily in equity securities of companies operating in the healthcare sector. The fund’s portfolio generally comprises a diversified mix of domestic and international healthcare issuers, spanning pharmaceuticals, biotechnology, medical devices, healthcare services, and related industries.

The fund employs a fundamental, research-driven approach to select investments, focusing on companies with strong balance sheets, innovative product pipelines and the potential for sustainable revenue growth.